Related Experiment Videos
Down syndrome, transient myeloproliferative syndrome, and leukemia: bridging development and neoplasia
Journal of Pediatric Hematology/Oncology
|March 21, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinical resistance associated with a novel MAP2K1 mutation in a patient with Langerhans cell histiocytosis.
Pediatric blood & cancer·2018
Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.
Journal of experimental & clinical cancer research : CR·2017
A phase IIa study of afuresertib, an oral pan-AKT inhibitor, in patients with Langerhans cell histiocytosis.
Pediatric blood & cancer·2016
Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: In memory of Bob Arceci.
Pediatric blood & cancer·2016
Comparison of Safety and Outcomes Between Laparoscopic and Open Resection of Small Hepatoblastoma Tumors in Children.
Journal of pediatric hematology/oncology·2026
Self-Efficacy and Knowledge in Cardiotoxicity Management Among Pediatric Oncology Nurses: A Cross-Sectional Mediation Analysis.
Journal of pediatric hematology/oncology·2026
Ovarian Dysfunction After Gonadotoxic Therapy in Childhood Cancer Survivors: A Cross-Sectional Study From a Resource-Limited Setting.
Journal of pediatric hematology/oncology·2026
AI-Assisted Generation of Long-Term Follow-Up Recommendations for Survivors of Childhood Cancer and Hematopoietic Stem Cell Transplantation.
Journal of pediatric hematology/oncology·2026
Influenza-Like Illness in Children With Cancer: Incidence, Predictors, and Outcomes From a Tertiary Cancer Center in India.
Journal of pediatric hematology/oncology·2026